0310-0657 : Lynparza 50 mg Oral Capsule
| NDC: | 0310-0657 |
| Labeler: | Astrazeneca Pharmaceuticals Lp |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Lynparza |
| Dosage Form: | Oral Capsule |
| Application #: | NDA206162 |
| Rev. Date: |
Appearance:
| Markings: | AstraZeneca;logo;printed;in;black;ink |
| Shapes: |
Capsule |
| Colors: |
 White |
| Size (mm): | 22 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 0310-0657-58: 112 CAPSULE IN 1 BOTTLE (0310‑0657‑58)
Active Ingredients:
- Olaparib
Dosage Strength:
- 50 mg
Inactive Ingredients:
- Hypromelloses
- Titanium Dioxide
- Gellan Gum (Low Acyl)
- Potassium Acetate
- Shellac
- Ferrosoferric Oxide
- Isopropyl Alcohol
- Butyl Alcohol
- Propylene Glycol
- Ammonia
- Lauroyl Peg-32 Glycerides
Pharmaceutical Classes:
- Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
- Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0310-0668 Lynparza 100 mg Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
- 0310-0679 Lynparza 150 mg Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0310-0625Next: 0310-0668 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.